S-ICD, Effortless

May 9, 2016 — The mid to long-term results from the EFFORTLESS study, the largest subcutaneous implantable cardioverter-defibrillator (S-ICD) registry in the world, show the device provides reliable treatment for ventricular tachyarrhythmias. This is the first report on the fully enrolled EFFORTLESS cohort and includes real-world outcomes of almost 1,000 patients implanted with an S-ICD. Positive results showing longevity during three- and up to five-year follow-ups were presented at Heart Rhythm 2016, the Heart Rhythm Society (HRS) annual meeting.

May 9, 2016 – A new, large study shows that 95.7 percent of individual leads were successfully removed using a procedure called transvenous lead extraction (TLE). The ELECTRa (European Lead Extraction ContTRolled) Registry, hosted by the European Heart Rhythm Association (EHRA) a registered branch of the European Society of Cardiology (ESC), is the first multinational, multi-center, prospective registry of consecutive patients undergoing TLE. 

Expert Venous Management

This course takes venous education to the next level.
- Limited to 75 participants.
- Basic knowledge of venous disease required.
- Attendees will learn the advanced management of venous disease
- Attendees submit cases prior to course and best ones are selected by faculty to discuss.
- Attendees are active participants.
- Small Faculty-Attendee Ratio = Lots of faculty interaction

Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if anticoagulation levels are not properly managed, according to a new study from researchers at the Intermountain Medical Center Heart Institute.

The largest risk-directed study by a national hospital system demonstrates a 40 percent decline in bleeding events for percutaneous coronary intervention (PCI) patients and a significant reduction in pharmacy costs.

The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement providing cardiologists, oncologists and internal medicine physicians guidance for treating patients facing concomitant cardiovascular disease and cancer.

May 6, 2016 — Cardiovascular Systems Inc. shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Fla.

LAA — How to Close the Left Atrial Appendage

Anticoagulation for stroke prevention in atrial fibrillation is difficult in clinical practice - with Coumadin and also with NOACS. Left atrial appendage closure has been shown to be superior to anticoagulation regarding stroke prevention, bleeding complications and even mortality. Several devices now have CE mark and/or FDA approval and many others are already in clinical trials. This two-day course is designed to give you an overview on all aspects of this treatment modality.

Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon Angioplasty – Below-the-Knee (TOBA-BTK) clinical study were presented at the SCAI 2016 conference.

May 5, 2016 — The Society for Cardiovascular Angiography and Interventions (SCAI) published an update to its 2012 paper outlining best practices in the cardiac catheterization laboratory (CCL), or cath lab. The paper, “SCAI Expert Consensus Statement: 2016 Best Practices in the Cardiac Catheterization Laboratory,” was published online in Catheterization and Cardiovascular Interventions, SCAI’s official journal.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now